T1	pharmacokinetics 16 31	Bioavailability
T3	food 152 156	food
T4	population 205 230	healthy female volunteers
T5	pharmacokinetics 382 404	Elimination half-lives
T6	mealTime 417 422	after
T7	pharmacokinetics 483 493	absorption
T2	drug 65 75	oxprenolol
T8	mealTime 79 111	fasted and nonfasted individuals
T9	pharmacokinetics 161 174	plasma levels
T10	drug 566 576	oxprenolol
T11	drug 178 188	oxprenolol
T12	food 423 427	food
T13	food 352 356	food
T14	mode 446 453	tablets
T15	mode 542 549	tablets
T16	interaction 299 320	no significant trends
T17	pharmacokinetics 324 344	plasma drug profiles
T18	pharmacokinetics 529 541	slow-release
T19	pharmacokinetics 242 254;272 284	conventional formulations
T20	mealTime 698 730	fasted and nonfasted individuals
T21	pharmacokinetics 674 694	plasma-drug profiles
T22	pharmacokinetics 433 445	conventional
T23	pharmacokinetics 259 284	slow-release formulations
T24	pharmacokinetics 35 47	conventional
T25	pharmacokinetics 52 64	slow-release
